Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-text

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

 

Research Article


Pharmacokinetic Study of Nifedipine in Healthy Adult Male Human Volunteers

 

M Ahmad1*, T Ahmad2, RA Sultan3 and G Murtaza1 

1Department of Pharmacy, Faculty of Pharmacy and Alternative Medicines, The Islamia University of Bahawalpur, Bahawalpur 63100, 2HEJ Research Institute of Chemistry, University of Karachi, Karachi, 3Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.

*Corresponding author:  E-mail: ma786_786@yahoo.com  Tel: +92-62-9255243, 300-9682258 (cell); Fax: +92-62-9255565

 

Received: 2 February 2009                                                                    Revised accepted: 12 June 2009

 

Tropical Journal of Pharmaceutical Research, October 2009; 8(5): 385-391

 

Abstract

 

Purpose: To evaluate the pharmacokinetics of nifedipine in healthy adult Pakistani subjects.

Methods: Each of six fasting volunteers received 20 mg nifedipine (2 x Adalat® 10 mg capsules) orally once and then another one week later. Their blood samples were obtained at regular time intervals and analysed by HPLC. Using the non-compartmental approach, plasma levels of nifedipine were employed to compute their individual disposition kinetics, including Cmax (maximum plasma concentration), Tmax (time to reach maximum plasma concentration), MRT (mean residence time), AUC0-∞ (area under curve), AUMC0-∞ (area under first moment curve) and Ka (absorption rate constant).

Results: The suggested therapeutic level of nifedipine for the treatment of hypertension (15-35 ng.mL-1) was achieved in all six volunteers within 0.25 h after dose administration, and maintained for more than 6 h. Tmax was 1.58 h and Cmax varied from 140 – 300 ng.mL-1. Mean absorption rate constant was 2.22 h-1 while mean absorption half-life was 0.43 h. The mean elimination rate constant was 0.16 h-1 while 5.7 h was recorded for terminal half-life. AUC0-¥, AUMC0-¥ and MRT were 1879.86 ng.h.mL-1, 8244.04 ng.h2.mL-1 and 4.2 h, respectively.

Conclusion: This study confirms the rapid absorption of nifedipine in humans. AUC was similar to that previously reported for Nigerians but slightly lower than that stated in the literature for other south Asian races. Further studies on large segments of the local population using the non-compartmental model for kinetic analysis is recommended.

 

Keywords: Nifedipine; Pharmacokinetics; Non-compartmental model; Pakistani subjects.

Copyright@2002-2013. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net